These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 421234)

  • 1. Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu.
    LeRoy AF; Lutz RJ; Dedrick RL; Litterst CL; Guarino AM
    Cancer Treat Rep; 1979 Jan; 63(1):59-71. PubMed ID: 421234
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.
    King FG; Dedrick RL; Farris FF
    J Pharmacokinet Biopharm; 1986 Apr; 14(2):131-55. PubMed ID: 3746636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic variability and radiation sensitization by dichlorodiammineplatinum(II) complexes in Salmonella typhimurium cells.
    Richmond RC
    Radiat Res; 1984 Sep; 99(3):596-608. PubMed ID: 6382408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model independent pharmacokinetic study of cis-dichlorodiammineplatinum (II).
    Dumas M; d'Athis P; de Gislain C; Escousse A; Guerrin J; Autissier N
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):430-3. PubMed ID: 4044076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).
    DeSimone PA; Yancey RS; Coupal JJ; Butts JD; Hoeschel JD
    Cancer Treat Rep; 1979 Jun; 63(6):951-60. PubMed ID: 466654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neutron activation analysis in modelling the elimination from the kidneys of cis-dichlorodiammineplatinum].
    Brovtsyn VK
    Med Radiol (Mosk); 1986 Feb; 31(2):42-5. PubMed ID: 3951347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. I: On the effects of intravesical instillation of cis-diamminedichloroplatinum in normal beagle dogs].
    Hirao Y; Iwai A; Yoshie T; Moriya A; Matsuki H; Yoshida K; Sanma S; Kubota K; Ohara S; Babaya K
    Hinyokika Kiyo; 1985 Jan; 31(1):31-8. PubMed ID: 4039525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ; Friedlos F
    Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo.
    Ambrose KR; Lowrey JS
    Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).
    Casper ES; Kelsen DP; Alcock NW; Young CW
    Cancer Treat Rep; 1979; 63(11-12):2023-5. PubMed ID: 575066
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.
    Farris FF; King FG; Dedrick RL; Litterst CL
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):13-39. PubMed ID: 4040567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).
    Vermorken JB; van der Vijgh WJ; Pinedo HM
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced cellular uptake of cis-dichlorodiammine-platinum by benzaldehyde.
    Dornish JM; Melvik JE; Pettersen EO
    Anticancer Res; 1986; 6(4):583-8. PubMed ID: 3752939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.
    Melvik JE; Dornish JM; Pettersen EO
    Br J Cancer; 1992 Aug; 66(2):260-5. PubMed ID: 1503898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
    Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
    Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
    Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia.
    Esposito M; Vannozzi MO; Viale M; Pellecchia C; Merlo F; Cadoni A; Cafaggi S; Parodi B; Lerza R; Poirier MC
    Anticancer Res; 1993; 13(5A):1511-6. PubMed ID: 8239529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.